loadpatents
Patent applications and USPTO patent grants for Gur; Chamutal.The latest application filed is for "attenuated or inactivated pathogenic escherichia coli for treating urogenital cancer".
Patent | Date |
---|---|
Attenuated or inactivated pathogenic Escherichia coli for treating urogenital cancer Grant 10,918,677 - Mandelboim , et al. February 16, 2 | 2021-02-16 |
Attenuated Or Inactivated Pathogenic Escherichia Coli For Treating Urogenital Cancer App 20180333439 - MANDELBOIM; Ofer ;   et al. | 2018-11-22 |
Method of treating type 1 diabetes by administering NKp46 polypeptide Grant 8,980,244 - Mandelboim , et al. March 17, 2 | 2015-03-17 |
Method For Treating Type 1 Diabetes App 20130280209 - MANDELBOIM; Ofer ;   et al. | 2013-10-24 |
Method of treating diabetes by administering an anti-NKp46 antibody Grant 8,420,092 - Mandelboim , et al. April 16, 2 | 2013-04-16 |
Use Of Nkp46 For Preventing Diabetes App 20120076753 - Mandelboim; Ofer ;   et al. | 2012-03-29 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.